Liang J - Search Results

1

Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.

de Groot J, Liang J, Kong LY, Wei J, Piao Y, Fuller G, Qiao W, Heimberger AB. de Groot J, et al. Among authors: liang j. Oncotarget. 2012 Sep;3(9):1036-48. doi: 10.18632/oncotarget.663. Oncotarget. 2012. PMID: 23013619 Free PMC article.

2

Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.

Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV, de Groot JF. Piao Y, et al. Among authors: liang j. Neuro Oncol. 2012 Nov;14(11):1379-92. doi: 10.1093/neuonc/nos158. Epub 2012 Sep 10. Neuro Oncol. 2012. PMID: 22965162 Free PMC article.

3

Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition.

Piao Y, Liang J, Holmes L, Henry V, Sulman E, de Groot JF. Piao Y, et al. Among authors: liang j. Clin Cancer Res. 2013 Aug 15;19(16):4392-403. doi: 10.1158/1078-0432.CCR-12-1557. Epub 2013 Jun 26. Clin Cancer Res. 2013. PMID: 23804423

4

Neutrophils promote the malignant glioma phenotype through S100A4.

Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N, de Groot JF. Liang J, et al. Clin Cancer Res. 2014 Jan 1;20(1):187-98. doi: 10.1158/1078-0432.CCR-13-1279. Epub 2013 Nov 15. Clin Cancer Res. 2014. PMID: 24240114 Free PMC article.

5

Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy.

Liang J, Piao Y, Henry V, Tiao N, de Groot JF. Liang J, et al. Oncotarget. 2015 Oct 13;6(31):31479-92. doi: 10.18632/oncotarget.5491. Oncotarget. 2015. PMID: 26362401 Free PMC article.

6

LINC02466 promotes the progression of hepatocellular carcinoma through the mTOR pathway.

Liu S, Quan Z, Liang J, Wang F, Yan H, Wang Z, Tang B, Qin X. Liu S, et al. Among authors: liang j. Discov Oncol. 2024 Nov 6;15(1):623. doi: 10.1007/s12672-024-00999-x. Discov Oncol. 2024. PMID: 39503938

7

Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease.

Liang J, Kim N, Yang JD. Liang J, et al. Transl Gastroenterol Hepatol. 2024 Oct 12;9:67. doi: 10.21037/tgh-24-41. eCollection 2024. Transl Gastroenterol Hepatol. 2024. PMID: 39503040 Free PMC article. Review.

8

Analysis of Baseline Molecular Factors Associated With the Risk of Central Nervous System Progression Among Alectinib-Treated Patients With ALK-Positive NSCLC.

Song L, Yan H, Xu Q, Zhou C, Liang J, Lin S, Zhang R, Yu J, Xia Y, Yang N, Zeng L, Zhang Y. Song L, et al. Among authors: liang j. JTO Clin Res Rep. 2024 Sep 17;5(12):100729. doi: 10.1016/j.jtocrr.2024.100729. eCollection 2024 Dec. JTO Clin Res Rep. 2024. PMID: 39502496 Free PMC article.

9

Nanoparticles in Subunit Vaccines: Immunological Foundations, Categories, and Applications.

Liang J, Yao L, Liu Z, Chen Y, Lin Y, Tian T. Liang J, et al. Small. 2024 Nov 6:e2407649. doi: 10.1002/smll.202407649. Online ahead of print. Small. 2024. PMID: 39501996 Review.

10

The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B-Cell Lymphoma.

Zhu Z, Jiang W, Zhou J, Maldeney AR, Liang J, Yang J, Luo W. Zhu Z, et al. Among authors: liang j. Cancer Med. 2024 Nov;13(21):e70342. doi: 10.1002/cam4.70342. Cancer Med. 2024. PMID: 39501600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,831 results

Search Page

Filters